Perspective · 3 Nov 2025
EditorialPublished 2016
A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double Standard DNA/RNA Binding Molecules with Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti Cancer Drugs for Cancer Cells Treatment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chemotherapists have been fascinated for a long time with phenomenon of anti–cancer drugs. This editorial generally associated with anti-cancer compounds, now extends equally well to medicinal and pharmaceutical chemistry . Despite this continuing very frequent use in the scientific literature, anti–cancer drugs like many other and useful and popular chemical concepts is non–reductive and lacks an unambiguous basis. It has no precise quantitative definition and is not directly measureable experimentally. In other words, anti– cancer compounds are a virtual quantity, rather than a physical observable. Hence, the chemistry of anti–cancer drugs has been attractive to chemotherapists. In addition, the interest to the chemistry of nanoparticles is due to the fact that nanoparticles are important synthetic materials in the preparation of anti–cancer compounds.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Chemotherapy: Open Access.
Opinion · 3 Nov 2025
Evaluation of Surgical Radiotherapy and Chemotherapy in the Treatment of Gynaecological Malignancies
Research article · 18 Aug 2025
Response Evaluation to Oxaliplatin-Based Adjuvant Chemotherapy after Curative Resection between Right and Left-Sided Stage II and III Colon Cancer: A Retrospective Survival Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChemotherapy: Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Heidari A”
